Mohsen Monirialamdari
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mohsen Monirialamdari has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Aleksandra Marchwicka
Institute of Molecular and Industrial Biotechnology, Faculty of Biotechnology and Food Sciences, Lodz University of Technology, 90-537 Lodz, Poland
1 shared publication - Anna Albrecht
Institute of General and Ecological Chemistry Faculty of Chemistry Lodz University of Technology Łódź Poland
1 shared publication - Daria Kamińska
Institute of Molecular and Industrial Biotechnology, Faculty of Biotechnology and Food Sciences Lodz University of Technology Lodz Poland
1 shared publication - Edyta Gendaszewska-Darmach
Faculty of Biotechnology and Food Sciences, Institute of Molecular and Industrial Biotechnology, Lodz University of Technology, Lodz, Poland
1 shared publication - Katarzyna Magdalena Błażewska
Institute of Organic Chemistry, Lodz University of Technology, Łódź, Poland
1 shared publication
Latest Publications
- Open Access
- 29 December 2023
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 60 (10) , 1265-1268
Decarboxylative photoinduced ligand-to-metal charge transfer reaction: synthesis of 2-substituted chroman-4-ones
This manuscript describes studies on the decarboxylative photoinduced ligand-to-metal charge transfer reaction for the synthesis of 2-substituted chroman-4-ones.
- 29 December 2023
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 60 (10) , 1265-1268
Open AccessDecarboxylative photoinduced ligand-to-metal charge transfer reaction: synthesis of 2-substituted chroman-4-ones
This manuscript describes studies on the decarboxylative photoinduced ligand-to-metal charge transfer reaction for the synthesis of 2-substituted chroman-4-ones.
- Open Access
- 12 May 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (10) , 5424
Protein Prenyltransferases and Their Inhibitors: Structural and Functional Characterization
Protein prenylation is a post-translational modification controlling the localization, activity, and protein–protein interactions of small GTPases, including the Ras superfamily. This covalent attachment of either a farnesyl (15 carbon) or a geranylgeranyl (20 carbon) isoprenoid group is catalyzed by four prenyltransferases, namely farnesyltransferase (FTase), geranylgeranyltransferase type I (GGTase-I), Rab geranylgeranyltransferase (GGTase-II), and recently discovered geranylgeranyltransferase type III (GGTase-III). Blocking small GTPase activity, namely inhibiting prenyltransferases, has been proposed as a potential disease treatment method. Inhibitors of prenyltransferase have resulted in substantial therapeutic benefits in various diseases, such as cancer, neurological disorders, and viral and parasitic infections. In this review, we overview the structure of FTase, GGTase-I, GGTase-II, and GGTase-III and summarize the current status of research on their inhibitors.
- 12 May 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (10) , 5424
Open AccessProtein Prenyltransferases and Their Inhibitors: Structural and Functional Characterization
Protein prenylation is a post-translational modification controlling the localization, activity, and protein–protein interactions of small GTPases, including the Ras superfamily. This covalent attachment of either a farnesyl (15 carbon) or a geranylgeranyl (20 carbon) isoprenoid group is catalyzed by four prenyltransferases, namely farnesyltransferase (FTase), geranylgeranyltransferase type I (GGTase-I), Rab geranylgeranyltransferase (GGTase-II), and recently discovered geranylgeranyltransferase type III (GGTase-III). Blocking small GTPase activity, namely inhibiting prenyltransferases, has been proposed as a potential disease treatment method. Inhibitors of prenyltransferase have resulted in substantial therapeutic benefits in various diseases, such as cancer, neurological disorders, and viral and parasitic infections. In this review, we overview the structure of FTase, GGTase-I, GGTase-II, and GGTase-III and summarize the current status of research on their inhibitors.